A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis
Part of paid clinical trials in Oceanside, California.
- Sponsor
- argenx
- Study ID
- NCT06284954
- Phase
- PHASE2
- Status
- Active Not Recruiting
Conditions
- Dermatomyositis
- Myositis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Empasiprubart IV — BIOLOGICALIntravenous infusion with Empasiprubart IV
- Placebo IV — OTHERIntravenous infusion with Placebo IV
Study Details
This study will evaluate the safety and efficacy of empasiprubart compared with placebo in adult participants with dermatomyositis (DM). The study duration will be approximately 92 weeks for all participants. After the screening period, eligible participants will be randomized in a 2:1 ratio to receive either empasiprubart or placebo, respectively, during the treatment period (duration of 25 weeks). At the end of the treatment period, all the participants will enter a safety follow-up period (duration of 65 weeks).
Key Dates
- Start date
- Aug 20, 2024
- Status verified
- Sep 2025
- Primary completion
- Nov 30, 2026
- Completion
- Nov 30, 2026
Study Design
- Enrollment
- 3 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: EmpasiprubartPatients receiving Empasiprubart IV
- Placebo Comparator: PlaceboPatients receiving Placebo IV
Primary Outcome Measure
Incidence of adverse events (AEs) [ Time Frame: Up to 90 weeks ]
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Profound Research LLC | Oceanside | California | 92056 | - |
| Omega Research Debary, LLC | DeBary | Florida | 32713 | - |
| University of Florida Health (UF) - Endocrinology - Medical Specialties - Medical Plaza | Gainesville | Florida | 32610 | - |
| Homestead Associates in Research, Inc. | Homestead | Florida | 33033 | - |
| Life Clinical Trials | Margate | Florida | 33063 | - |
| Advance Medical Research Center | Miami | Florida | 33135 | - |
| Integral Rheumatology and Immunology Specialists (IRIS) | Plantation | Florida | 33324 | - |
| D and H Tamarac Research, LLC Center | Tamarac | Florida | 33321 | - |
| Wright State Physicians Health Center | Dayton | Ohio | 45324 | - |
Find similar trials in Oceanside, CA
By research site
Profound Research LLC· Oceanside, CAOmega Research Debary, LLC· DeBary, FLUniversity of Florida Health (UF) - Endocrinology - Medical Specialties - Medical Plaza· Gainesville, FLHomestead Associates in Research, Inc.· Homestead, FLLife Clinical Trials· Margate, FLAdvance Medical Research Center· Miami, FL
Related Studies
- Environmental Risk Factors for the Anti-synthetase SyndromeRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Miami, Florida
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Birmingham, Alabama
- A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]PHASE3 · Recruiting · Pfizer · Glendale, Arizona
- A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory MyopathyPHASE3 · Enrolling By Invitation · argenx · Phoenix, Arizona